KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) Return on Invested Capital (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Return on Invested Capital for 16 consecutive years, with 0.05% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Invested Capital rose 31.0% to 0.05% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.05%, a 31.0% increase, with the full-year FY2025 number at 0.05%, up 40.0% from a year prior.
  • Return on Invested Capital was 0.05% for Q4 2025 at Bristol Myers Squibb, up from 0.09% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.03% in Q3 2022 to a low of 0.39% in Q1 2021.
  • A 5-year average of 0.16% and a median of 0.08% in 2022 define the central range for Return on Invested Capital.
  • Peak YoY movement for Return on Invested Capital: plummeted -35bps in 2021, then skyrocketed 31bps in 2022.
  • Bristol Myers Squibb's Return on Invested Capital stood at 0.04% in 2021, then tumbled by -30bps to 0.05% in 2022, then dropped by -17bps to 0.06% in 2023, then tumbled by -551bps to 0.36% in 2024, then surged by 85bps to 0.05% in 2025.
  • Per Business Quant, the three most recent readings for BMY's Return on Invested Capital are 0.05% (Q4 2025), 0.09% (Q3 2025), and 0.12% (Q2 2025).